The use of a compound of general formula (I) : or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prevention of a disease or condition characterised by apopto
induced pluripotent stem cellsretinal degenerationtransplantationTo report a case of sequential central retinal vein occlusion and ophthalmic artery occlusion in a patient with primary antiphospholipid syndrome. Observational case report. Color fundus photography, fluorescein angiography, and optical coherence ...
Intravenous treatment of choroidal neovascularization by photo-targeted nanoparticles Current treatments of wet age-related macular degeneration require repeated injections of active drugs into the vitreous. Here Wang et al. develop nanoparticles that when injected intravenously can be targeted to the eye by...
for example, diabetic retinopathy, macular degeneration, retinal vein impediment, and retinal separation retinal vascular malady, laser medical procedure including the retina, visual provocative ailment, intra-vitreal infusions for wet macular degeneration, and careful treatment of complex...
There is currently no effective treatment for degenerative diseases except in the case of AMD [19]. AMD is a disease of the retina characterized by the degeneration of the cells in the RPE and the photoreceptors in the central neural retina. AMD is the leading cause of blindness in the ...
et al. Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA). Mol. Vis. 11, 152–162 (2005). CAS PubMed Google Scholar Zhong, Z. et al. Seven novel variants expand the spectrum of RPE65-related Leber congenital amaurosis ...
Treatment: Traditional treatment can not stop degeneration and necrosis in retinal nerve cells and pigment cells. There has been no effective treatment before. In recent years, through more than ten years treatment experience, Wu Medical Center (WMC) found that stem cells can have a good treatment...
Photoreceptor apoptosis is an important pathogenesis of retinal degeneration and a primary cause of vision loss with limited treatment methods. Mesenchymal stem/stromal cells-derived small extracellular vesicles (MSC-sEVs) have shown therapeutic value in
Breakdown of vitreal and retinal tissues (such as inlattice degeneration) The rate at which a rhegmatogenous retinal detachment develops varies and can range from a few hours to several months. This is dependent on where the detachment takes place. RRDs tend to develop more quickly than other...
Age-related macular degeneration in 2025- opportunities and challenges Chui Ming Gemmy Cheung Editorial26 Feb 2025Eye Volume: 39, P: 1231-1232 Hybrid closed loop and intensive insulin delivery technology: Reviewing the effect of improving ‘time in range’ glucose levels on diabetic retinopathy ...